Cigna Corporation reported strong 2022 results, driven by growth in both Evernorth and Cigna Healthcare. The company is carrying great momentum into 2023, with a focus on innovation and growth to improve health and vitality.
Cigna's 2022 shareholders’ net income was $6.7 billion, or $21.30 per share, including an after-tax gain of $1.3 billion, or $4.26 per share, primarily from the Chubb transaction.
Adjusted income from operations for 2022 was $7.3 billion, or $23.27 per share, reflecting growth in Evernorth and Cigna Healthcare.
Cigna's outlook for full year 2023 adjusted revenues is projected to be at least $187.0 billion.
Cigna’s outlook for full year 2023 consolidated adjusted income from operations is projected to be at least $7.33 billion, or at least $24.60 per share.
Cigna's outlook for full year 2023 includes adjusted revenues projected to be at least $187.0 billion and consolidated adjusted income from operations projected to be at least $7.33 billion, or at least $24.60 per share. This outlook includes the impact of expected future share repurchases and anticipated 2023 dividends.